March 28th 2025
A look ahead to 5 key regulatory decisions scheduled to take place during the second quarter of 2025, from a monoclonal antibody to topical psoriasis treatments.
February 20th 2025
Meeting to discuss COVID-19 vaccine in kids 6 months to 4 years postponed
February 11th 2022The US Food and Drug Administration announces that the meeting to discuss extending the emergency use authorization for the Pfizer/BioNTech vaccine to children aged 6 months to 4 years has been postponed until data on a third dose has been studied.
COVID-19 vaccine exposure in utero not linked to adverse neonatal outcomes
February 11th 2022The safety of the Pfizer/BioNTech COVID-19 vaccine in pregnant women, for both mother and baby, has been dependent on observation during the rollout. A large population trial provides further support for the vaccine’s safety.